New substances for prostate cancer

In recent years, there has been great progress in the treatment of metastatic prostate cancer. The aim of this project, undertaken on behalf of Janssen-Cilag and in collaboration with opinion leaders in the field of urology, was to prepare a review covering new studies in this indication, with a special focus on testosterone.


The article appeared in the prestigious Springer journal »Der Urologe« and made an important contribution to the understanding of new substances in the treatment of prostate cancer.